a:head - launched to transform CNS drug discovery

a:head bio AG, an Austrian biotech company focusing on the development of next generation therapeutics for the treatment of brain disorders based on human cerebral organoids has recently been incorporated.

The new venture is based on groundbreaking technology developed at the Institute of Molecular Biotechnology GmbH (IMBA) in Vienna, Austria and substantially funded by red-stars.com data AG, a Viennese high-tech holding company.

Read the full story here